Remove Clinic Management Remove Communication Remove Documentation
article thumbnail

Leading speciality pharmacies in pharma

Pharmaceutical Technology

Adherence management. Communication and follow-up with the physician. Clinical interventions, and psychosocial and emotional assessment. . Clinical interventions, and psychosocial and emotional assessment. Benefits investigation. Dispensing of speciality pharmaceuticals and shipping coordination.

article thumbnail

The Incredible Shrinking Exemption: FDA Final CDS Guidance Would Significantly Narrow the Scope of Exempt Clinical Decision Support Software Under the Cures Act

The FDA Law Blog

Javitt — On September 28, 2022, the FDA issued the long anticipated final Clinical Decision Support Software Guidance (CDS Guidance), which replaces the revised draft guidance document from 2019. Other medical information.

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Highlights from ESCMID Global 2024: AI, climate change and AMR

Hospital Pharmacy Europe

Bhat, head of department – central laboratory and consultant microbiologist and infection control officer at St Martha’s Hospital, Bengaluru, India, showcased her work with ChatGPT in the clinical microbiology laboratory. In microbiologically documented HAIs, 32% of microorganisms were resistant to antimicrobials.

article thumbnail

Challenges & Opportunities in Emerging Digital Health Technologies

ISPE

Wireless medical devices use wireless radio frequency communication such as wifi, Bluetooth, and cellular/mobile phone technology. Category I: SaMD that provides information to inform clinical management for a disease or condition in a nonserious situation or condition is a Category I and is considered to be of low impact.

article thumbnail

Challenges & Opportunities in Emerging Digital Health Technologies

ISPE

Wireless medical devices use wireless radio frequency communication such as wifi, Bluetooth, and cellular/mobile phone technology. Category I: SaMD that provides information to inform clinical management for a disease or condition in a nonserious situation or condition is a Category I and is considered to be of low impact.